Pionyr Immunotherapeutics

Pionyr Immunotherapeutics

Pionyr Immunotherapeutics

Raised
$70M
Follow us
Alexa global traffic share
Latest funding
$62,000,000
Venture capital (Series B) - 2017
Osage University Partners Sofinnova Ventures OrbiMed +4
$8,000,000
Venture capital (Series A) - 2017
Osage University Partners SV Life Sciences OrbiMed +1
Team Size
1–10
Employees
$8,000,000 Venture capital (Series A)
prnewswire , Venture Funding News

Pionyr Immunotherapeutics Closes Financing with Focus on Developing Antibody-based Immuno-oncology Therapeutics